Education
About Us
Working with TipRanks
Follow Us
Neurogene Inc. (NGNE)
:NGNE
Total Valuation
Neurogene has a market cap or net worth of $164.23M. The enterprise value is $39.60M.
Market Cap$164.23M
Enterprise Value$39.60M
Share Statistics
Neurogene has 14.93M shares outstanding. The number of shares has decreased by -2.65% in one year.
Shares Outstanding14.93M
Owned by Insiders14.83%
Owned by Instutions0.36%
Financial Efficiency
Neurogene’s return on equity (ROE) is -0.24 and return on invested capital (ROIC) is -25.53%.
Return on Equity (ROE)-24.21%
Return on Assets (ROA)-22.38%
Return on Invested Capital (ROIC)-25.53%
Return on Capital Employed (ROCE)-25.77%
Revenue Per Employee$8,644.86
Profits Per Employee-$702,280.374
Employee Count107
Asset Turnover<0.01
Inventory Turnover0.00
Valuation Ratios
The current PE Ratio of Neurogene is -5.16. Neurogene’s PEG ratio is -0.09.
PE Ratio-5.16
PS Ratio418.98
PB Ratio1.25
Price to Fair Value1.25
Price to FCF-5.43
Price to Operating Cash Flow-5.49
PEG Ratio-0.09
Income Statement
In the last 12 months, Neurogene had revenue of $925.00K and earned -$75.14M in profits. Earnings per share was -$4.43.
Revenue$925.00K
Gross Profit-$15.64M
Operating Income-$82.61M
Pretax Income-$75.14M
Net Income-$75.14M
EBITDA-71.88M
Earnings Per Share (EPS)-4.43
Cash Flow
In the last 12 months, operating cash flow was -$70.60M and capital expenditures -$808.00K, giving a free cash flow of -$71.41M billion.
Operating Cash Flow-$70.60M
Free Cash Flow-$71.41M
Free Cash Flow per Share-$4.78
Dividends & Yields
Neurogene pays an annual dividend of , resulting in a dividend yield of
Dividend Per Share
Dividend Yield
Payout Ratio
Free Cash Flow Yield-18.43%
Earnings Yield-19.39%
Stock Price Statistics
Beta2.50
52-Week Price Change-70.61%
50-Day Moving Average15.57
200-Day Moving Average30.46
Relative Strength Index (RSI)43.25
Average Volume (3m)324.03K
Important Dates
Neurogene upcoming earnings date is May 9, 2025, During Market Hours.
Last Earnings DateMar 24, 2025
Next Earnings DateMay 9, 2025
Ex-Dividend Date―
Financial Position
Neurogene as a current ratio of 20.84, with Debt / Equity ratio of 0.04
Current Ratio20.84
Quick Ratio20.84
Debt to Market Cap0.03
Net Debt to EBITDA1.73
Interest Coverage Ratio-6.88K
Taxes
In the past 12 months, Neurogene has paid -$1.00 in taxes.
Income Tax-$1.00
Effective Tax Rate0.00%
Enterprise Valuation
Neurogene EV to EBITDA ratio is -3.66, with an EV/FCF ratio of -3.69.
EV to Sales284.75
EV to EBITDA-3.66
EV to Free Cash Flow-3.69
EV to Operating Cash Flow-3.73
Balance Sheet
Neurogene has $312.40M in cash and marketable securities with $14.24M in debt, giving a net cash position of -$298.17M billion.
Cash & Marketable Securities$312.40M
Total Debt$14.24M
Net Cash-$298.17M
Net Cash Per Share-$19.97
Tangible Book Value Per Share$18.31
Margins
Gross margin is 100.00%, with operating margin of -8930.27%, and net profit margin of -8123.68%.
Gross Margin100.00%
Operating Margin-8930.27%
Pretax Margin-8123.68%
Net Profit Margin-8123.68%
EBITDA Margin-7771.35%
EBIT Margin-8122.38%
Analyst Forecast
The average price target for Neurogene is $51.50, which is 11.43% higher than the current price. The consensus rating is Strong Buy
Price Target$51.50
Price Target Upside368.18%
Analyst ConsensusStrong Buy
Analyst Count6
Revenue Growth Forecast
EPS Growth Forecast-140.77%